AxSpA: Adalimumab biosimilar equally effective as IL-17 inhibitor in hindering radiographic progression Presented ByProf. Xenofon Baraliakos, Rheumazentrum Ruhrgebiet, Germany TrialPhase 3, SURPASS ConferenceEULAR 2023 31 July, 2023 06:22